TANG KEVIN purchased $222K of BOLD (indirect holdings)
TANG KEVIN purchased 91,585 indirectly-held shares of Boundless Bio, Inc. (BOLD) at an average of $2.42 ($2.42–$2.48, $0.22M total) across 3 trades over 2026-07-09 to 2026-07-13.
How this was made
The 30-second read
Why it matters
The newest concrete fact is the disclosed open-market purchase by a 10% owner over July 9-13 at an average price of $2.4247, totaling about $222.1k.
Market read
Primarily sentiment and positioning information from an insider transaction, with limited standalone trading catalyst value.
What to watch
No accompanying operational update is provided, so traders should avoid extrapolating this purchase into near-term fundamental expectations.
Background
The article is an SEC Form 4 insider transaction disclosure for Boundless Bio, Inc. (BOLD).
Ticker impact
SEC Form 4 shows 10% owner Tang Kevin bought 91,585 shares of Boundless Bio at about $2.42 to $2.48 between July 9-13.
Near-term impact likely limited, with any effect more sentiment-driven than fundamental.
The filing is primary-source and time-stamped, but it is an indirect holding purchase without accompanying guidance, trial, or deal news.
Market effects
No sector-level signal; this is a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Indirect holdings and lack of a 10b5-1 plan detail can reduce interpretability; buying may reflect liquidity or portfolio mechanics rather than a new outlook.
Key entities
- issuerBoundless Bio, Inc.
Company whose shares were purchased; subject of the Form 4 disclosure.
- insiderTang Kevin
10% owner reporting indirect open-market purchases via Form 4.